• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大型队列中戊型肝炎血清学和分子检测的综合评估

Comprehensive Evaluation of Hepatitis E Serology and Molecular Testing in a Large Cohort.

作者信息

Anastasiou Olympia E, Thodou Viktoria, Berger Annemarie, Wedemeyer Heiner, Ciesek Sandra

机构信息

Institute of Virology, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.

Department of Gastroenterology and Hepatology, University Hospital of Essen, 45147 Essen, Germany.

出版信息

Pathogens. 2020 Feb 19;9(2):137. doi: 10.3390/pathogens9020137.

DOI:10.3390/pathogens9020137
PMID:32093070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7168254/
Abstract

INTRODUCTION

Reliable and cost-effective diagnostics for hepatitis E virus (HEV) infection are necessary. The aim of our study was to investigate which diagnostic test is most accurate to detect HEV infection in immunocompetent and immunosuppressed patients in a real world setting.

PATIENTS AND METHODS

We performed a retrospective analysis of 1165 patients tested for HEV antibodies and HEV PCR at the same time point. Clinical, laboratory and virological data were taken from patient charts. HEV IgA was measured in a subgroup of 185 patients.

RESULTS

HEV RNA was detectable in 61 patients (5.2%); most of them (n = 49, 80.3%/n = 43, 70.5%) were HEV IgM+ and IgG+; however, 12 patients (19.6%) were HEV RNA positive/HEV IgM negative and 17 patients (27.8%) were HEV RNA positive/HEV IgG negative. Ten HEV RNA positive patients (16.4%) had neither HEV IgG nor IgM antibodies. Importantly, all of them were immunosuppressed. HEV IgA testing was less sensitive than HEV IgM for HEV diagnosis.

CONCLUSIONS

HEV infection can be overlooked in patients without HEV specific antibodies. Performing PCR is necessary to diagnose or exclude HEV infection in immunocompromised hosts. In immunocompetent patients, a screening based on HEV antibodies (IgG/IgM) is sufficient.

摘要

引言

戊型肝炎病毒(HEV)感染需要可靠且经济高效的诊断方法。我们研究的目的是调查在现实环境中,哪种诊断测试对于检测免疫功能正常和免疫抑制患者的HEV感染最为准确。

患者与方法

我们对1165例同时进行HEV抗体和HEV PCR检测的患者进行了回顾性分析。临床、实验室和病毒学数据均取自患者病历。对185例患者的亚组进行了HEV IgA检测。

结果

61例患者(5.2%)可检测到HEV RNA;其中大多数(n = 49,80.3%/n = 43,70.5%)HEV IgM和IgG均为阳性;然而,12例患者(19.6%)HEV RNA阳性但HEV IgM阴性,17例患者(27.8%)HEV RNA阳性但HEV IgG阴性。10例HEV RNA阳性患者(16.4%)既没有HEV IgG也没有IgM抗体。重要的是,他们均为免疫抑制患者。HEV IgA检测对HEV诊断的敏感性低于HEV IgM。

结论

没有HEV特异性抗体的患者可能会漏诊HEV感染。对于免疫功能低下的宿主,进行PCR检测对于诊断或排除HEV感染是必要的。对于免疫功能正常的患者,基于HEV抗体(IgG/IgM)的筛查就足够了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/ba3b35a21bf2/pathogens-09-00137-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/691ea8e7e721/pathogens-09-00137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/3f7fe9aa4d1a/pathogens-09-00137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/ba3b35a21bf2/pathogens-09-00137-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/691ea8e7e721/pathogens-09-00137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/3f7fe9aa4d1a/pathogens-09-00137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a3/7168254/ba3b35a21bf2/pathogens-09-00137-g003.jpg

相似文献

1
Comprehensive Evaluation of Hepatitis E Serology and Molecular Testing in a Large Cohort.大型队列中戊型肝炎血清学和分子检测的综合评估
Pathogens. 2020 Feb 19;9(2):137. doi: 10.3390/pathogens9020137.
2
Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.用于免疫功能低下和免疫功能正常患者的选定商业 HEV IgM 和 IgG ELISA 的诊断性能。
J Clin Virol. 2013 Dec;58(4):629-34. doi: 10.1016/j.jcv.2013.10.010. Epub 2013 Oct 17.
3
Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients.抗 HEV 检测在免疫抑制患者急性戊型肝炎诊断中的应用。
J Clin Virol. 2013 Dec;58(4):624-8. doi: 10.1016/j.jcv.2013.10.003. Epub 2013 Oct 15.
4
Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection.CMV 和 EBV 的血清学交叉反应导致急性戊型肝炎病毒感染的诊断出现问题。
J Med Virol. 2014 Mar;86(3):478-83. doi: 10.1002/jmv.23827. Epub 2013 Nov 8.
5
Significance of serum IgA in patients with acute hepatitis E virus infection.急性戊型肝炎病毒感染患者血清IgA的意义。
World J Gastroenterol. 2006 Jun 28;12(24):3919-23. doi: 10.3748/wjg.v12.i24.3919.
6
Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.VIDAS® ANTI-HEV IgM 和 IgG 检测法的性能特征。
J Clin Virol. 2019 Mar;112:10-14. doi: 10.1016/j.jcv.2019.01.005. Epub 2019 Jan 11.
7
Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.在法国免疫功能低下人群的队列中,戊型肝炎病毒抗体和 RNA 基因组的流行率。
J Clin Virol. 2012 Apr;53(4):346-9. doi: 10.1016/j.jcv.2012.01.001. Epub 2012 Jan 30.
8
Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.一项大型队列研究中五种抗戊型肝炎病毒IgG和IgM检测方法的诊断性能
J Clin Microbiol. 2016 Mar;54(3):549-55. doi: 10.1128/JCM.02343-15. Epub 2015 Dec 9.
9
Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients.一种用于检测免疫功能正常和免疫功能低下患者中抗戊型肝炎病毒免疫球蛋白M的新型快速检测方法的性能。
J Clin Virol. 2015 Sep;70:101-104. doi: 10.1016/j.jcv.2015.07.302. Epub 2015 Jul 26.
10
Hepatitis E virus infection dynamics and organic distribution in naturally infected pigs in a farrow-to-finish farm.一个自繁自养猪场中自然感染猪的戊型肝炎病毒感染动态及器官分布
Vet Microbiol. 2008 Nov 25;132(1-2):19-28. doi: 10.1016/j.vetmic.2008.04.036. Epub 2008 May 4.

引用本文的文献

1
Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays.免疫功能低下癌症患者中戊型肝炎的血清学一致性较低:三种抗戊型肝炎病毒检测方法的比较研究
Antibodies (Basel). 2025 Mar 24;14(2):27. doi: 10.3390/antib14020027.
2
Clinical utility of two-step hepatitis E virus IgM antibody testing in a low-prevalence setting: A 10-year retrospective multicenter study.低流行率环境下戊型肝炎病毒IgM抗体两步检测法的临床应用:一项10年回顾性多中心研究
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000611. eCollection 2025 Jan 1.
3
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.

本文引用的文献

1
EASL Clinical Practice Guidelines on hepatitis E virus infection.欧洲肝脏研究学会(EASL)丙型肝炎病毒感染临床实践指南
J Hepatol. 2018 Jun;68(6):1256-1271. doi: 10.1016/j.jhep.2018.03.005. Epub 2018 Mar 31.
2
Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies.HBV 感染患者中无可检测到抗-HBc 抗体者的临床病程和核心变异性。
J Clin Virol. 2017 Aug;93:46-52. doi: 10.1016/j.jcv.2017.06.001. Epub 2017 Jun 8.
3
Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.
异基因造血细胞移植受者中的戊型肝炎病毒感染流行病学
Open Forum Infect Dis. 2023 Nov 24;10(12):ofad595. doi: 10.1093/ofid/ofad595. eCollection 2023 Dec.
4
Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils.免疫功能正常和免疫抑制蒙古沙鼠中急性和持续性基因型 3 戊型肝炎病毒感染的不同疾病特征。
PLoS Pathog. 2023 Sep 13;19(9):e1011664. doi: 10.1371/journal.ppat.1011664. eCollection 2023 Sep.
5
Development and clinical validation of a one-step pentaplex real-time reverse transcription PCR assay for detection of hepatitis virus B, C, E, Treponema pallidum, and a human housekeeping gene.开发并验证了一种一步五重实时逆转录 PCR 检测方法,用于检测乙型肝炎病毒、丙型肝炎病毒、戊型肝炎病毒、梅毒螺旋体和一个人类管家基因。
BMC Infect Dis. 2023 May 25;23(1):358. doi: 10.1186/s12879-023-08240-w.
6
Hepatitis E Virus Infection in Cancer Patients.戊型肝炎病毒感染与癌症患者。
Transplant Cell Ther. 2022 Nov;28(11):788.e1-788.e5. doi: 10.1016/j.jtct.2022.08.020. Epub 2022 Aug 27.
7
The prevalence of HEV among non-A-C hepatitis in Qatar and efficiency of serological markers for the diagnosis of hepatitis E.在卡塔尔,非甲-戊型肝炎中戊型肝炎病毒的流行情况以及血清学标志物在戊型肝炎诊断中的效率。
BMC Gastroenterol. 2021 Jun 15;21(1):266. doi: 10.1186/s12876-021-01841-2.
8
Towards the Improved Accuracy of Hepatitis E Diagnosis in Vulnerable and Target Groups: A Global Perspective on the Current State of Knowledge and the Implications for Practice.提高弱势群体和目标人群戊型肝炎诊断准确性:关于当前知识状况及实践意义的全球视角
Healthcare (Basel). 2021 Jan 29;9(2):133. doi: 10.3390/healthcare9020133.
戊型肝炎病毒(HEV)抗体检测的性能:基于德国与家猪或野猪有直接接触个体的样本的比较分析
Med Microbiol Immunol. 2017 Jun;206(3):277-286. doi: 10.1007/s00430-017-0503-4. Epub 2017 Apr 10.
4
Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal.戊型肝炎病毒血清流行病学:尼泊尔地震后献血者中的一项研究
BMC Infect Dis. 2016 Nov 25;16(1):707. doi: 10.1186/s12879-016-2043-8.
5
Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.2011年德国献血者中的戊型肝炎:无症状感染自然病程调查
Euro Surveill. 2016 Sep 1;21(35). doi: 10.2807/1560-7917.ES.2016.21.35.30332.
6
Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15.戊型肝炎病毒:2014/15年欧洲人类流行病学状况评估
J Clin Virol. 2016 Sep;82:9-16. doi: 10.1016/j.jcv.2016.06.010. Epub 2016 Jun 23.
7
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases.新型抗戊型肝炎病毒总抗体、IgA抗体和IgM抗体免疫测定法:在意大利献血者以及慢性肝病或肾病患者中的流行情况
Dig Liver Dis. 2016 May;48(5):536-541. doi: 10.1016/j.dld.2016.01.007. Epub 2016 Feb 10.
8
Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.一项大型队列研究中五种抗戊型肝炎病毒IgG和IgM检测方法的诊断性能
J Clin Microbiol. 2016 Mar;54(3):549-55. doi: 10.1128/JCM.02343-15. Epub 2015 Dec 9.
9
Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature.与戊型肝炎病毒感染相关的肝外表现:文献综述。
Gastroenterol Rep (Oxf). 2016 Feb;4(1):1-15. doi: 10.1093/gastro/gov042. Epub 2015 Sep 10.
10
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.原发性免疫缺陷、继发性免疫缺陷以及伴有免疫调节异常的自身免疫患者的疫苗接种。
Immunotherapy. 2015;7(12):1273-92. doi: 10.2217/IMT.15.74. Epub 2015 Aug 20.